| 000 | 00981 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513140921.0 | ||
| 264 | 0 | _c19980505 | |
| 008 | 199805s 0 0 fre d | ||
| 022 | _a1262-3636 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeutenegger, M | |
| 245 | 0 | 0 |
_a[Escaping oral hypoglycemic agents in type 2 diabetes: importance and limitations of transitory optimized insulin therapy]. _h[electronic resource] |
| 260 |
_bDiabetes & metabolism _cFeb 1998 |
||
| 300 |
_a80-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aInsulin _xtherapeutic use |
| 700 | 1 | _aBertin, E | |
| 700 | 1 | _aGrulet, H | |
| 773 | 0 |
_tDiabetes & metabolism _gvol. 24 _gno. 1 _gp. 80-4 |
|
| 999 |
_c9501615 _d9501615 |
||